BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Spiliopoulos S, Reppas L, Filippiadis D, Delvecchio A, Conticchio M, Memeo R, Inchingolo R. Irreversible electroporation for the management of pancreatic cancer: Current data and future directions. World J Gastroenterol 2023; 29(2): 223-231 [PMID: 36687122 DOI: 10.3748/wjg.v29.i2.223]
URL: https://www.wjgnet.com/1948-5204/full/v29/i2/223.htm
Number Citing Articles
1
星昊 薛. Advances in the Treatment of Unresectable Pancreatic CancerJournal of Clinical Personalized Medicine 2024; 3(02): 538 doi: 10.12677/jcpm.2024.32079
2
Robert C. G. Martin, Rebekah Ruth White, Malcolm M. Bilimoria, Michael D. Kluger, David A. Iannitti, Patricio M. Polanco, Chet W. Hammil, Sean P. Cleary, Robert Evans Heithaus, Theodore Welling, Carlos H. F. Chan. Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry StudyCancers 2024; 16(23): 3894 doi: 10.3390/cancers16233894
3
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
4
Xinyu Liu, Hao Wang, Zilin Zhao, Qikai Zhong, Xinlei Wang, Xing Liu, Junzhi Chen, Conghui Han, Zhenduo Shi, Qing Liang. Advances in irreversible electroporation for prostate cancerDiscover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01570-4